Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

CWP232228

SKU: orb1940802

Description

CWP232228, a potent and selective Wnt / β-catenin signaling inhibitor, antagonizes the binding of β-catenin to T-cell factor (TCF) in the nucleus. CWP232228 inhibits the formation and metastasis of tumors by inhibiting the growth of breast cancer and liver cancer stem cells (CSC) without toxicity.(In Vitro):CWP232228 (0.01-100 μM; 48 hours) inhibited cell proliferation, and IC50 values in mouse (4T1) and human (MDA-MB-435) breast cancer cell lines were 2 and 0.8 μM, respectively. CWP232228 (0.01-10 μM; 48 hours) inhibited cell proliferation in Hep3B, Huh7 and HepG2 cells with IC50 of 2.566, 2.630 and 2.596 μM, respectively.(In Vivo):CWP232228 (100 mg/kg, administered i.p.; daily; mice with 4T1 cell tumors for 21 days; mice with MDA-MB-435 cell tumors for 60 days) resulted in a significant reduction in tumor volume.

Images & Validation

Key Properties

CAS Number1144044-02-9
MW717.63
Purity>98% (HPLC)
FormulaC33H34N7Na2O7P
SMILESCn1cc2cccc(CN3C[C@@H]4N(N(CC=C)CC(=O)N4[C@@H](Cc4ccc(OP(=O)(O[Na])O[Na])cc4)C3=O)C(=O)NCc3ccccc3)c2n1
TargetWnt/beta/catenin
SolubilityIn Vitro: H2O : 62.5 mg/mL (87.09 mM)

Bioactivity

In Vivo
CWP232228 (100 mg/kg, administered i.p.; daily; 21days for mice bearing 4T1 cell tumors; 60 days for mice bearing MDA-MB-435 cell tumors) results in a significant reduction in tumor volume. Animal model: 7-week-old female Balb/c and NOD/SCID mice bearing 4T1 or MDA-MB-435 cell tumors. Dosage: 100 mg/kg. Administration: Administered i.p.; daily; 21days for mice bearing 4T1 cell tumors, 60 days for mice bearing MDA-MB-435 cell tumors. Result: Treatment resulted in a significant reduction in tumor volume.
In Vitro
CWP232228 (0.01-100 μM; 48 hours) inhibits cell proliferation with IC50 values are 2 and 0.8 μM in mouse (4T1) and human (MDA-MB-435) breast cancer cell lines, respectively. CWP232228 (0.01-10 μM; 48 hours) inhibits cell proliferation with IC50s of 2.566, 2.630, and 2.596 μM in Hep3B, Huh7 and HepG2 cells, respectively. Cell Proliferation Assay Cell line: Mouse (4T1) and human (MDA-MB-435) breast cancer cell lines. Concentration: 0.01, 0.1, 1, 10, 100 μM Incubation time: 48 hours. Result: IC50s were 2 and 0.8 μM for 4T1 and MDA-MB-435 cell lines, respectively. Cell Proliferation Assay Cell line: Hepatocellular carcinoma cell lines HepG2, Huh7, and Hep3B. Concentration: 0.01, 0.1, 0.5, 1, 5, 10 μM Incubation time: 48 hours. Result: IC50s were 2.566, 2.630, and 2.596 μM for Hep3B, Huh7 and HepG2 cells, respectively.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • CWP232228 [orb1309804]

    98.87% (May vary between batches)

    1144044-02-9

    717.63

    C33H34N7Na2O7P

    1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

200 mg
500 mg
5 mg
$ 780.00
10 mg
$ 1,120.00
25 mg
$ 1,740.00
50 mg
$ 2,340.00
100 mg
$ 3,040.00